Alexander Introduces Pharmaceutical Compounding Legislation

Wednesday, May 15, 2013

Chairman of the Senate Health, Education, Labor and Pensions Committee Senator Tom Harkin (D-Iowa) and Ranking Member Lamar Alexander (R-Tn.), with Senators Pat Roberts (R-Ks.) and Al Franken (D-Mn.) and other members of the HELP Committee, on Wednesday introduced legislation—the Pharmaceutical Compounding Quality and Accountability Act—that would improve the safety of compounded human and animal drugs by making clear the compounding oversight responsibilities of state and federal authorities. 

Chairman Harkin and Ranking Member Alexander also announced that the Committee will convene for an executive session next Wednesday, to consider the compounding bill, along with newly-introduced legislation to strengthen and improve the drug distribution supply chain.

In April, Senators Harkin, Alexander, Roberts, and Franken released draft legislation relating to pharmaceutical compounding and requested that stakeholders provide feedback on the policy merits, potential unintended consequences, and opportunities to improve the legislative language. Additionally, the HELP Committee held a legislative hearing in early May to listen to more in-depth testimonies from experts and stakeholders to improve the draft bill.  An updated one-pager, section-by-section and the Pharmaceutical Compounding Quality and Accountability Act can be viewed on the HELP Committee website.

The Pharmaceutical Compounding Quality and Accountability Act makes a clear distinction between traditional compounding—which will continue to be regulated primarily by state pharmacy boards—and compounding manufacturers that make sterile products without, or in advance of, a prescription and sell those products across state lines. The compounding manufacturers would be regulated by the U.S. Food and Drug Administration (FDA). It clarifies a national, uniform set of rules for compounding manufacturers while preserving the states’ primary role in traditional pharmacy regulation.

“We cannot wait for the next public health crisis—as we saw with the New England Compounding Company disaster that led to more than 50 deaths and caused serious illness in 700 more—to act to improve the safety of compounded drugs,” Chairman Harkin said. “The Pharmaceutical Compounding Quality and Accountability Act will help protect the public from unsafe compounded products and clarify FDA authority over high-risk compounding practices. I am proud of the bipartisan effort that members of this Committee have put forth in drafting this bill, and I am appreciative of the helpful and constructive feedback received from stakeholders throughout this process. I look forward to considering this bill in an executive session of the Committee next week.”

Senator Alexander said, “My primary goal with this legislation is to erase the confusion over who regulates pharmacies and manufacturing facilities, and make it clear exactly who oversees each business. Putting one agency on the flagpole for each of these businesses will mean greater safety for American families, so they don’t have to question whether the drugs they take are safe.”

“I am proud of the work we have done to craft a solution that protects patients, while preserving the practice of traditional pharmacy compounding,” Senator Roberts said. “After reviewing stakeholder comments, we made a concerted effort to address their concerns in this legislation. This bipartisan bill is balanced, clear and will leave no questions about the regulatory oversight of compounded drugs. I urge my colleagues to support it.”

"We've seen far too many deaths in Minnesota, and nationwide, because some pharmacies in this country have acted more like drug manufacturers – without following rigorous safety rules that drug manufacturers must follow,” said Senator Franken. “This bipartisan legislation will keep Minnesotans safe by ensuring that drug manufacturers have appropriate oversight, and that responsible pharmacies don't see any unnecessary restrictions."

In addition to distinguishing between pharmacies and manufacturers, and clarifying proper oversight of each, the legislation sets forth requirements on compounding manufacturers. Compounding manufacturers must register with the FDA and tell the agency what products they have made; make products under a pharmacist’s oversight and in compliance with good manufacturing practices; and investigate and report when things go wrong.

The bill allows FDA to identify categories of drugs that currently cannot be safely compounded; preserves and enhances current protections regarding the ingredients from which drugs are compounded; and preserves the line between compounding manufacturers and traditional manufacturers by placing prohibitions on wholesale distribution of compounded products.

The legislation also encourages communication among states and increases communication between states and the FDA. FDA will designate a point of contact for a State Board of Pharmacy to notify the agency if it appears that a state-licensed business should be registered as a compounding pharmacy. The FDA must notify the state within 15 days if it determines that business is a compounding manufacturer.

Erlanger’s Data Management Platform For Stroke Recognized As A Finalist By Cleveland Clinic During IT Challenge

The Cleveland Clinic 2016 Medical Innovation Summit recognizes CEREBROS, Erlanger Health System’s partner in data management for stroke, as one of four finalists from more than 90 submissions of cutting-edge solutions to improve health care during this year’s IT Challenge.     As the first Neurovascular Information System designed for neurology and stroke programs, ... (click for more)

BlueCross Adds Hearing Benefits For Seniors In 2017

BlueCross BlueShield of Tennessee intends to help the large number of seniors who suffer from hearing loss by offering high-quality, affordable hearing benefits in its 2017 Medicare Advantage plans known as BlueAdvantage. In a partnership with TruHearing, a national hearing aid provider, BlueAdvantage members will be eligible for an annual hearing exam, plus two hearing aids ... (click for more)

2 Witnesses To A Murder Refuse To Testify At Jury Trial

Two men who prosecutors say witnessed a murder in Hixson on Jan. 31, 2014, on Wednesday refused to tell their story to a jury. Criminal Court Judge Barry Steelman ordered Andrew Biro and Jacob Tyler "T.Y." Keel to answer questions from prosecutor Lance Pope, but they both refused. Biro had said during testimony in General Sessions Court that Christopher Levi Parker threatened ... (click for more)

PETA And Humane Educational Society Offer Reward For Torture-Killing Of Dog After Envelope Mailed From Chattanooga

An envelope postmarked from Chattanooga and containing a photo of a dog strung between two trees arrived at PETA's office in Virginia Tuesday, along with the severed ear of a dog. PETA members are offering a reward of $5,000-and the Humane Educational Society of Chattanooga has added another $1,000-for information leading to the arrest and conviction of the person(s) responsible ... (click for more)

Accountability Doesn't Have To Be A Bad Word

Am I making a difference? Isn’t that the basic question we all ask ourselves, and seek to demonstrate to others?  Ronald Reagan said:  “Some people spend an entire lifetime wondering if they made a difference in the world. But, the Marines don't have that problem.”   We would argue teachers do not have that problem either.    Educators make a huge difference ... (click for more)

Roy Exum: Saving A Life & More

About 40 years ago I was at an afternoon football practice when one of those who was also watching from the fence was bitten by a bumble bee or yellow jacket or whatever it was and almost died from anaphylactic shock. Luckily an athletic trainer had an EpiPen, jammed it into the man’s thigh and it is believed to have saved the victim’s life. For years I kept an EpiPen on the top ... (click for more)